HIPAA does not treat every pharmaceutical record the same way. Product data, stability data, formulation records, and supply chain data may be sensitive, but they are not automatically PHI. The risk changes when drug information connects to an identifiable person.

Managing content effectively is essential in using ai tools such as digital humans and AI Avatars in Healthcare, involving content reviews, regulation, approval, and supervision to adhere to regulatory standards and guidelines.

Teams deploying Ai should create a plan which connects each control to a legal policy requirement.

Focus: Actionable steps to align MDM with HIPAA compliance